On February 17, 2023, the Federal Court ruled that Sandoz and Sun Pharma may counterclaim as of right against non-asserted patent claims in separate actions pursuant to the Patented Medicines (Notice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results